Atlas Trials

Decitabine Treatment in HPV-Induced Anogenital and Head and Neck Cancer Patients After Radiotherapy or as Novel Late Salvage

Clinical trial NCT04252248 · TERMINATED

Trial details

NCT number
NCT04252248
Sponsor
University Hospital Heidelberg
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Head and Neck CancerAnogenital Cancer
Start date
2019-10-11
Primary completion
2021-06-15
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.